Evidence map›Paper›PMID 35740700›Full record

ArticleCancers2022

Can

Vetri Sudar Jayaprakasam, Peter Gibbs, Natalie Gangai, Raazi Bajwa, Ramon E Sosa, Randy Yeh, Megan Greally, Geoffrey Y Ku, Marc J Gollub, Viktoriya Paroder

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vetri Sudar JayaprakasamMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-7360-9867
Peter GibbsDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Natalie GangaiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-0603-7165
Raazi BajwaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ramon E SosaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Randy YehMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Megan GreallyMater Private Hospital, D07 WKW8 Dublin, Ireland.
Geoffrey Y KuDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-0448-1038
Marc J GollubDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-6008-0730
Viktoriya ParoderDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-4356-8256

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NIH HHS P30 CA008748
6 · The paper itself

Abstract

This study aimed to assess the usefulness of radiomics features of

Indexed as

esophageal squamous cell carcinomaoverall survivalPET/CTprogression-free survivalradiomics

Identifiers

PMID35740700
PMCPMC9221147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.